Company News
2020 Medicare Fee Schedule For PAD Testing Available
Every year, the reimbursement of PAD tests change. We provide an updated schedule each year to help you plan for the year ahead.
Social Determinants of Health
Racial Disparities & PAD
An article published in FierceHealthcare highlighted the epidemic of peripheral artery disease (PAD), and specifically how it impacts communities of color. The article, written by Foluso Fakorede, M.D. of Cardiovascular Solutions of Central Mississippi, and is focused on preventing some …
PAD Treatment
Does exercise intensity reduce the impact of PAD?
A recent study published in the Journal of the American Heart Association sought to determine if the intensity of exercise a patient is engaged in has an impact on how effective exercise is for preventing and addressing PAD (Peripheral Artery …
PAD Symptoms
PAD & Intermittent Claudication
New study on PAD and claudication A recent study published in Endovascular Today examined patients experiencing symptomatic peripheral artery disease (PAD) and other associated adverse medical events such as amputations and myocardial infarction. The authors noted that only 20% – …
Company News
We will never forget
18 years ago today, America was forever changed by the events of 9/11. Countless lives were changed forever, but the lives of many were saved by the brave and selfless actions of first responders and other heroes.
Company News
Biomedix adds VP of Sales, Jeff Oestereich
Biomedix, a provider of front-line diagnostic solutions for delivering value-based care, is proud to announce the addition of Jeff Oestereich as the Vice President of Sales. Jeff is highly experienced, with over 30 years in medical technology sales, including more …
Company News
2019 Medicare Fee Schedule Available
Every year, the reimbursement of PAD tests change. We provide an updated schedule each year to help you plan for the year ahead.
Company News
Pharmaceutical company announces intent to leverage PADnet for FDA Phase III Trial
AngioSoma (OTC: SOAN) recently announced their intent to work with Biomedix to use PADnet for clinical research and trials, to evaluate the efficacy of their pharmaceutical intervention for PAD. AngioSoma intends to use the PADnet device to select patients for …
Company News
Biomedix featured in Vein Magazine
The Fall 2018 edition of Vein Magazine features an article from Biomedix titled: 4 Critical Reasons to Expand Your Collaborative Care Network with Non-Invasive Vascular Assessments. Highlighting our collaborative care model, here are highlights from the 4 reasons we highlighted in …
PAD Risk Factors
CDC reports that 1 in 7 US adults have diabetes
The CDC (Centers for Disease Control and Prevention) is now reporting that 14% of US adults had diabetes between 2013 and 2016, which means that 30 million Americans have diabetes. Although 1 in 7 Americans does have diabetes, it is …